Pendal Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $86M | Buy |
|
|||||
|
2022
Q3 | $86.1M | Sell |
|
|||||
|
2022
Q2 | $101M | Buy |
|
|||||
|
2022
Q1 | $619K | Sell |
|
|||||
|
2021
Q4 | $524K | Sell |
|
|||||
|
2021
Q3 | $607K | Sell |
|
|||||
|
2021
Q2 | $3.54M | Sell |
|
|||||
|
2021
Q1 | $3.77M | Buy |
|
|||||
|
2020
Q4 | $3.06M | Buy |
|
|||||
|
2020
Q3 | $1.96M | Sell |
|
|||||
|
2020
Q2 | $2.25M | Buy |
|
|||||
|
2020
Q1 | $1.7M | Buy |
|
|||||
|
2019
Q4 | $1.16M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $8.94M | Buy |
|
|||||
|
2018
Q2 | $7.27M | Sell |
|
|||||
|
2018
Q1 | $10.5M | Sell |
|
|||||
|
2017
Q4 | $10.4M | Sell |
|
|||||
|
2017
Q3 | $13M | Buy |
|
|||||
|
2017
Q2 | $5.46M | Buy |
|